BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24531716)

  • 1. Modification of sialylation is associated with multidrug resistance in human acute myeloid leukemia.
    Ma H; Zhou H; Song X; Shi S; Zhang J; Jia L
    Oncogene; 2015 Feb; 34(6):726-40. PubMed ID: 24531716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ST3GAL 4 and FUT 7 on sialyl Lewis X synthesis and multidrug resistance in human acute myeloid leukemia.
    Ma H; Zhou H; Li P; Song X; Miao X; Li Y; Jia L
    Biochim Biophys Acta; 2014 Sep; 1842(9):1681-92. PubMed ID: 24953795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal effect of ST6GAL 1 on multidrug resistance in human leukemia by regulating the PI3K/Akt pathway and the expression of P-gp and MRP1.
    Ma H; Cheng L; Hao K; Li Y; Song X; Zhou H; Jia L
    PLoS One; 2014; 9(1):e85113. PubMed ID: 24454800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-2,8-Sialyltransferase Is Involved in the Development of Multidrug Resistance via PI3K/Akt Pathway in Human Chronic Myeloid Leukemia.
    Zhang X; Dong W; Zhou H; Li H; Wang N; Miao X; Jia L
    IUBMB Life; 2015 Feb; 67(2):77-87. PubMed ID: 25855199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B4GALT family mediates the multidrug resistance of human leukemia cells by regulating the hedgehog pathway and the expression of p-glycoprotein and multidrug resistance-associated protein 1.
    Zhou H; Ma H; Wei W; Ji D; Song X; Sun J; Zhang J; Jia L
    Cell Death Dis; 2013 Jun; 4(6):e654. PubMed ID: 23744354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grape seed proanthocyanidin extract reverses multidrug resistance in HL-60/ADR cells via inhibition of the PI3K/Akt signaling pathway.
    Lin KN; Jiang YL; Zhang SG; Huang SY; Li H
    Biomed Pharmacother; 2020 May; 125():109885. PubMed ID: 32007917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interaction of WAVE1 and genes involved in multiple drug resistance in children with acute myeloblastic leukemia].
    Yang MH; Zhao MY; He YL; Wang MH; Wang Z; Xie M; Wu XS; Cao LZ
    Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):175-9. PubMed ID: 20426950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of sialylation mediates the invasive properties and chemosensitivity of human hepatocellular carcinoma.
    Zhao Y; Li Y; Ma H; Dong W; Zhou H; Song X; Zhang J; Jia L
    Mol Cell Proteomics; 2014 Feb; 13(2):520-36. PubMed ID: 24255131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of SCN5A overcomes ABC transporter-mediated multidrug resistance in acute myeloid leukemia through promoting apoptosis.
    Xu K; Zhuang XX; Shi XW
    Expert Rev Hematol; 2024; 17(1-3):87-94. PubMed ID: 38230679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FUT family mediates the multidrug resistance of human hepatocellular carcinoma via the PI3K/Akt signaling pathway.
    Cheng L; Luo S; Jin C; Ma H; Zhou H; Jia L
    Cell Death Dis; 2013 Nov; 4(11):e923. PubMed ID: 24232099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of LncRNA CRNDE suppresses proliferation and P-glycoprotein-mediated multidrug resistance in acute myelocytic leukemia through the Wnt/β-catenin pathway.
    Kang Y; Zhang S; Cao W; Wan D; Sun L
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32426817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway.
    Wang H; Jia XH; Chen JR; Yi YJ; Wang JY; Li YJ; Xie SY
    Int J Oncol; 2016 Dec; 49(6):2529-2537. PubMed ID: 27779650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia.
    Zhao L; Li Y; Song X; Zhou H; Li N; Miao Y; Jia L
    Oncotarget; 2016 Sep; 7(37):60074-60086. PubMed ID: 27527856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative effect of ZSTK474 alone or in combination with chemotherapeutic drugs on HL60 and HL60/ADR cells.
    Zhou Q; Chen Y; Zhang L; Zhong Y; Zhang Z; Wang R; Jin M; Gong M; Qiu Y; Kong D
    Oncotarget; 2017 Jun; 8(24):39064-39076. PubMed ID: 28388564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment outcome of multidrug resistance related mRNA expression and c-jun-N-terminal kinase activity in patients with acute myeloid leukemia].
    Do JH; Oh SH; Song EJ; Chung JS; Kang CD; Lee EY
    Korean J Lab Med; 2007 Aug; 27(4):229-36. PubMed ID: 18094581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts.
    Tazzari PL; Cappellini A; Ricci F; Evangelisti C; Papa V; Grafone T; Martinelli G; Conte R; Cocco L; McCubrey JA; Martelli AM
    Leukemia; 2007 Mar; 21(3):427-38. PubMed ID: 17215852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant mannosylation profile and FTX/miR-342/ALG3-axis contribute to development of drug resistance in acute myeloid leukemia.
    Liu B; Ma X; Liu Q; Xiao Y; Pan S; Jia L
    Cell Death Dis; 2018 Jun; 9(6):688. PubMed ID: 29880818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FLT3-ITD and MLL-PTD influence the expression of MDR-1, MRP-1, and BCRP mRNA but not LRP mRNA assessed with RQ-PCR method in adult acute myeloid leukemia.
    Nasilowska-Adamska B; Solarska I; Paluszewska M; Malinowska I; Jedrzejczak WW; Warzocha K
    Ann Hematol; 2014 Apr; 93(4):577-93. PubMed ID: 24030729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-glycoprotein and multidrug resistance-associated protein-1 expression in acute myeloid leukemia: Biological and prognosis implications.
    da Silveira Júnior LS; Soares VL; Jardim da Silva AS; Gil EA; Pereira de Araújo MDG; Merces Gonçalves CA; Paiva AS; Moura de Oliveira TM; Oliveira GHM; Kramer Cavacanti E Silva DG; de Araújo Moura Lemos TM; Moretti Rebecchi IM; de Farias Sales VS; Luchessi AD; Cavalcanti Júnior GB
    Int J Lab Hematol; 2020 Oct; 42(5):594-603. PubMed ID: 32452631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SIRT2 mediates multidrug resistance in acute myelogenous leukemia cells via ERK1/2 signaling pathway.
    Xu H; Li Y; Chen L; Wang C; Wang Q; Zhang H; Lin Y; Li Q; Pang T
    Int J Oncol; 2016 Feb; 48(2):613-23. PubMed ID: 26647771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.